MedPath

Assessment of the effects of pregabalin by the current perception threshold test in patients with chronic pruritus

Not Applicable
Completed
Conditions
Diseases of the skin and subcutaneous tissue
Registration Number
KCT0004215
Lead Sponsor
ational Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
61
Inclusion Criteria

Eligible participants were adults with chronic pruritus that persisted for more than 6 weeks and healthy individuals as a control group.

Exclusion Criteria

a history of diabetes mellitus, hepatobiliary disease, chronic renal failure, eczema, psoriasis, and other skin diseases, with overt inflammation improved by topical steroids or oral antihistamines, abnormal laboratory results, and an initial VAS score of lower than 3 or a duration of pruritus of less than 6 weeks

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
VAS score
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath